Salesforce
CRM
Apple
AAPL
Cisco
CSCO
Advanced Micro Devices
AMD
Alibaba
BABA
US Stock MarketDetailed Quotes
FATE Fate Therapeutics
- 1.925
- -0.255-11.70%
Close Dec 12 16:00 ET
- 1.931
- +0.006+0.33%
Post 16:31 ET
219.25MMarket Cap-1.17P/E (TTM)
2.220High1.900Low5.63MVolume2.220Open2.180Pre Close11.21MTurnover5.70%Turnover RatioLossP/E (Static)113.89MShares8.83052wk High0.61P/B190.17MFloat Cap1.90052wk Low--Dividend TTM98.79MShs Float121.160Historical High--Div YieldTTM14.68%Amplitude1.460Historical Low1.992Avg Price1Lot Size
About Fate Therapeutics Company
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolFATE
Company NameFate Therapeutics
Listing DateOct 1, 2013
Issue Price6.00
Founded2007
CEOMr. J. Scott Wolchko
MarketNASDAQ
Employees220
Fiscal Year Ends12-31
Address12278 Scripps Summit Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92131
Phone1-858-875-1800
Company Executives
- Name
- Position
- Salary
- J. Scott Wolchko
- Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer
- 3.52M
- Cindy Tahl
- Chief Legal and Compliance Officer
- 2.82M
- Dr. Bahram Valamehr, M.B.A.,PhD
- President, Research and Development
- 2.99M
- Dr. William H. Rastetter,PhD
- Chairman of the Board
- 253.25K
- Dr. John D. Mendlein, J.D.,PhD
- Vice Chairman of the Board
- 218.33K
- Dr. Neelufar Mozaffarian, F.A.C.R.
- Director
- --
- Timothy P. Coughlin
- Independent Director
- 231.75K
- Dr. Robert S. Epstein, M.D.,M.S.
- Independent Director
- 228.25K
- Dr. Karin Jooss, PhD
- Independent Director
- 227.82K
- Dr. Shefali Agarwal, M.D.,M.P.H.
- Independent Director
- 227.75K
- Dr. Robert M. Hershberg, M.D.,PhD
- Independent Director
- 221.75K
- Michael Lee
- Independent Director
- 216.75K
- Dr. Yuan Xu, PhD
- Independent Director
- 228.60K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.